{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T12:39:23Z","timestamp":1782563963564,"version":"3.54.5"},"reference-count":172,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,9]],"date-time":"2018-12-09T00:00:00Z","timestamp":1544313600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"DOG"},{"name":"GKJR"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.semarthrit.2018.11.004","type":"journal-article","created":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T21:28:09Z","timestamp":1543872489000},"page":"43-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["Update of the evidence based, interdisciplinary guideline for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis"],"prefix":"10.1016","volume":"49","author":[{"given":"A.","family":"Heiligenhaus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Minden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6907-1112","authenticated-orcid":false,"given":"C.","family":"Tappeiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Baus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Bertram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Deuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Foeldvari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"F\u00f6ll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Frosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Ganser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gaubitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"G\u00fcnther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2814-4327","authenticated-orcid":false,"given":"C.","family":"Heinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Horneff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Huemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Kopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lommatzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Michels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Ne\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Neudorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Pleyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Schulze-Koops","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Thurau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Zierhut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0791-3577","authenticated-orcid":false,"given":"H.W.","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2018.11.004_bib0001","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1007\/s00417-013-2436-y","article-title":"Tocilizumab treatment for refractory uveitis-related cystoid macular edema","volume":"251","author":"Adan","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0002","first-page":"1897","article-title":"Abatacept for refractory juvenile idiopathic arthritis-associated uveitis- a case report","volume":"35","author":"Angeles-Han","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0003","article-title":"Childhood arthritis and rheumatology research alliance consensus treatment plans for juvenile idiopathic arthritis-associated and idiopathic chronic anterior uveitis","author":"Angeles-Han","year":"2018","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0004","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1093\/rheumatology\/ket170","article-title":"Treatment choices of paediatric rheumatologists for juvenile idiopathic arthritis: etanercept or adalimumab","volume":"52","author":"Anink","year":"2013","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0005","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0161-6420(00)00658-8","article-title":"Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study","volume":"108","author":"Antcliff","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0006","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ajo.2007.08.018","article-title":"Infliximab to treat chronic noninfectious uveitis in children: retrospective case series with long-term follow-up","volume":"144","author":"Ardoin","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0007","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0161-6420(03)00092-7","article-title":"Mycophenolate mofetil as an immunomodulatory agent in the treatment of chronic ocular inflammatory disorders","volume":"110","author":"Baltatzis","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0008","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/eye.2000.84","article-title":"Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis","volume":"14","author":"Beritez-Del-Castillo","year":"2000","journal-title":"Eye"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0009","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.3899\/jrheum.120110","article-title":"Disease-modifying antirheumatic drug use in the treatment of juvenile idiopathic arthritis: a cross-sectional analysis of the CARRA registry","volume":"39","author":"Beukelman","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0010","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3109\/03009742.2015.1013983","article-title":"Leflunomide is associated with higher flare compared to methotrexate in treatment of chronic uveitis in juvenile idiopathic arthritis","volume":"44","author":"Bichler","year":"2015","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0011","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/bjo.2006.103721","article-title":"Adalimumab in the therapy of uveitis in childhood","volume":"91","author":"Biester","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0012","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ajo.2016.09.018","article-title":"Ocular hypotony in patients with juvenile idiopahic arthritis-associated uveitis","volume":"173","author":"B\u00f6hm","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0013","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.3899\/jrheum.151389","article-title":"Comparable efficacy of abatacept used as first-line or second-line biological agent for severe juvenile idiopathic arthritis-related uveitis","volume":"43","author":"Birolo","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0014","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00296-015-3231-3","article-title":"Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus","volume":"35","author":"Bou","year":"2015","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0015","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jaapos.2013.06.009","article-title":"Adalimumab therapy for refractory childhood uveitis","volume":"17","author":"Bravo-Ljubetic","year":"2013","journal-title":"J AAPOS"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0016","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00417-016-3497-5","article-title":"Discontinuation of long-term adalimumab treatment in patients with juvenile idiopathic arthritis-associated uveitis","volume":"255","author":"Breitbach","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0017","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/art.39940","article-title":"Anti-IL-6R tocilizumab for severe juvenile idiopathic arthritis-associated uveitis refractory to anti-TNF therapy. A multicenter study of 25 patients","volume":"69","author":"Calvo-Rio","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0018","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00417-005-0087-3","article-title":"Incidence and outcomes of uveitis in juvenile rheumatoid arthritis, a synthesis of the literature","volume":"244","author":"Carvounis","year":"2006","journal-title":"Graefe\u00b4s Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0019","first-page":"198","article-title":"Methotrexate and chronic uveitis associated with juvenile idiopathic arthritis","volume":"33","author":"Chan","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0020","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1089\/jop.2006.22.168","article-title":"Mycophenolate mofetil as an immunosuppressive agent in refractory inflammatory eye disease","volume":"22","author":"Choudhary","year":"2006","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0021","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/0002-9394(75)90689-3","article-title":"Ocular manifestations of juvenile rheumatoid arthritis","volume":"79","author":"Chylack","year":"1975","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0022","first-page":"1892","article-title":"Golimumab for uveitis","volume":"118","author":"Cordero-Coma","year":"2011","journal-title":"Ophthalmoogy"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0023","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jaapos.2013.07.014","article-title":"Preoperative cataract surgery use of an intravitreal dexamethasone implant (Ozurdex) in a patients with juvenile idiopathic arthritis and chronic anterior uveitis","volume":"17","author":"Cordero-Coma","year":"2013","journal-title":"J AAPOS"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0024","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/717598","article-title":"Golimumab as rescue therapy for refractory immune-mediated uveitis: a three-center experience","volume":"2014","author":"Cordero-Coma","year":"2014","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0025","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0161-6420(97)30329-7","article-title":"Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis","volume":"104","author":"Dana","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0026","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0002-9394(03)00315-5","article-title":"Laser flare photometry and complications of chronic uveitis in children","volume":"135","author":"Davis","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0027","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/bjo.87.7.879","article-title":"Visual loss in uveitis of childhood","volume":"87","author":"De Boer","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0028","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.ophtha.2012.02.018","article-title":"Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients","volume":"119","author":"Diaz-Llopis","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0029","first-page":"169","article-title":"Recurrent new-onset uveitis in a patient with rheumatoid arthritis during anti-TNFalpha treatment","volume":"59","author":"Di Gangi","year":"2007","journal-title":"Reumatismo"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0030","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/bjophthalmol-2011-301401","article-title":"A three-centre experience with adalimumab for the treatment of non-infectious uveitis","volume":"97","author":"Dobner","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0031","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/bjo.2006.094698","article-title":"Mycophenolate mofetil in the treatment of uveitis in children","volume":"91","author":"Doycheva","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0032","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/bjo.69.2.120","article-title":"Efficacy in anterior uveitis of two known steroids and topical tolmetin","volume":"69","author":"Dunne","year":"1985","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0033","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1136\/bjo.63.11.762","article-title":"Double-blind clinical trial of topical steroids in anterior uveitis","volume":"63","author":"Dunne","year":"1979","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0034","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0002-9394(02)02148-7","article-title":"Visual loss associated with paediatric uveitis in english primary and referral centers","volume":"135","author":"Edelsten","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0035","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/acr.20359","article-title":"Abatacept for refractory juvenile idiopathic arthritis-associated uveitis: two new cases","volume":"63","author":"Elhai","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0036","series-title":"AWMF guidance -manual and rules for guideline development","year":"2012"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0037","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1001\/archopht.121.12.1716","article-title":"Ocular-hypertensive and anti-inflammatory response to rimexolone therapy in children","volume":"121","author":"Fan","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0038","article-title":"Results of a multinational survey regarding the use of cyclosporine A in the treatment of juvenile idiopathic arthritis associated uveitis","author":"Foeldvari","year":"2006","journal-title":"EULAR, American College of Rheumatology (ACR) Meeting"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0039","first-page":"1146","article-title":"Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey","volume":"34","author":"Foeldvari","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0040","first-page":"362","article-title":"Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis","volume":"32","author":"Foeldvari","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0041","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/acr.22613","article-title":"Uveitis events during adalimumab, etanercept, and methotrexate therapy in juvenile idiopathic arthritis: data from the biologics in pediatric rheumatology registry","volume":"67","author":"Foeldvari","year":"2015","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0042","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0002-9394(14)72008-2","article-title":"Efficacy and safety of rimexolone 1% ophthalmic suspension vs 1% prednisolone acetate in the treatment of uveitis","volume":"122","author":"Foster","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0043","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1136\/bjo.2007.124081","article-title":"Biological response modifier therapy for refractory childhood uveitis","volume":"91","author":"Gallagher","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0044","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.ophtha.2006.04.038","article-title":"Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation","volume":"113","author":"Galor","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0045","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/560632","article-title":"Usefulness of adalimumab in the treatment of refractory uveitis associated with juvenile idiopathic arthritis","volume":"2013","author":"Garcia-De-Vicuna","year":"2013","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0046","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/092739490500192","article-title":"A review of evidence guiding the use of corticosteroids in the treatment of intraocular inflammation","volume":"12","author":"Gaudio","year":"2004","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0047","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/rheumatology\/40.8.907","article-title":"Efficacy and safety profile of cyclosporin A in the treatment of juvenile chronic (idiopathic) arthritis. Results of a 10-year prospective study","volume":"40","author":"Gerloni","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0048","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.2007.069484","article-title":"Focus on adverse events of tumour necrosis factor alpha blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study in 163 patients","volume":"67","author":"Gerloni","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0049","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1056\/NEJM199204163261602","article-title":"Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The pediatric rheumatology collaborative study group and the cooperative children's study group","volume":"326","author":"Giannini","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0050","first-page":"105","article-title":"Dauerprophylaxe der rezidivierenden spondylitischen Iridozyklitis durch Antimalarika und nichtsteroidale Antiphogistika","volume":"4","author":"Giordano","year":"1983","journal-title":"Z Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0051","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0002-9394(74)90229-3","article-title":"The use of chlorambucil in intractable idiopathic uveitis","volume":"78","author":"Godfrey","year":"1974","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0052","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/bjo.2009.173542","article-title":"Azathioprine as a treatment option for uveitis in patients with juvenile idiopathic arthritis","volume":"95","author":"Goebel","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0053","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1177\/112067210701700509","article-title":"Methotrexate for uveitis associated with juvenile idiopathic arthritis: value and requirement for additional anti-inflammatory medication","volume":"17","author":"Heiligenhaus","year":"2007","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0054","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/rheumatology\/kem053","article-title":"Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines","volume":"46","author":"Heiligenhaus","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0055","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1093\/rheumatology\/ker107","article-title":"Treatment of severe uveitis associated with juvenile idiopathic arthritis with anti-CD20 monoclonal antibody (rituximab)","volume":"50","author":"Heiligenhaus","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0056","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/acr.21674","article-title":"Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhood","volume":"64","author":"Heiligenhaus","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0057","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00296-011-2126-1","article-title":"Evidence-based guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis","volume":"32","author":"Heiligenhaus","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0058","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1007\/s00347-014-3130-0","article-title":"Statement of the German ophthalmological society, the retina society and the professional association of German ophthalmologists for intravitreal treatment of macular edema in uveitis","volume":"111","author":"Heiligenhaus","year":"2014","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0059","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0039-6257(91)90186-J","article-title":"Immunosuppressive drugs in immune and inflammatory ocular disease","volume":"35","author":"Hemady","year":"1991","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0060","first-page":"397","article-title":"Asymptomatic uveitis in children with chronic inflammatory bowel diseases","volume":"17","author":"Hofley","year":"1993","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0061","first-page":"71","article-title":"Sulphasalazine therapy in chronic uveitis of children with chronic arthritis","volume":"15","author":"Huang","year":"1997","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0062","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0063","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.ophtha.2006.01.005","article-title":"Favorable response to high-dose infliximab for refractory childhood uveitis","volume":"113","author":"Kahn","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0064","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/ard.62.1.88","article-title":"Recurrent uveitis in a patient with juvenile spondyloarthropathy associated with tumour necrosis factor alpha inhibitors","volume":"62","author":"Kaipiainen-Sepp\u00e4nen","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0065","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3109\/02713683.2010.486520","article-title":"Anti-TNF-alpha treatment: a possible promoter in endogenous uveitis? Observational report on six patients: occurrence of uveitis following etanercept treatment","volume":"35","author":"Kakkassery","year":"2010","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0066","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ajo.2010.08.021","article-title":"Relapse rate of uveitis post-methotrexate treatment in juvenile idiopathic arthritis","volume":"151","author":"Kalinina Ayuso","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0067","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1167\/iovs.15-17351","article-title":"Infiltration of plasma cells in the iris of children with ANA-positive uveitis","volume":"56","author":"Kalinina Ayuso","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0068","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1001\/archopht.1977.04450100096010","article-title":"Anterior uveitis in juvenile rheumatoid arthritis","volume":"95","author":"Kanski","year":"1977","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0069","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0039-6257(90)90026-R","article-title":"Juvenile arthritis and uveitis","volume":"34","author":"Kanski","year":"1990","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0070","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.ajo.2008.04.035","article-title":"Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence","volume":"146","author":"Kempen","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0071","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00417-010-1523-6","article-title":"Abatacept: a potential therapy in refractory cases of juvenile idiopathic arthritis-associated uveitis","volume":"249","author":"Kenawy","year":"2011","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0072","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1007\/s00296-011-2030-8","article-title":"Is it safe to use anti-TNF-a agents for tuberculosis in children suffering with chronic rheumatic disease?","volume":"32","author":"Kilic","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0073","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/bjo.82.7.737","article-title":"Cyclosporin A therapy in refractory non-infectious childhood uveitis","volume":"82","author":"Kilmartin","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0074","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1136\/annrheumdis-annrheumdis-2014-206747","article-title":"Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis","volume":"75","author":"Klotsche","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0075","first-page":"714","article-title":"Methotrexate treatment may prevent uveitis onset in patients with juvenile idiopathic arthritis: experiences and subgroup analysis in a cohort with frequent methotrexate use","volume":"34","author":"Kostik","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0076","first-page":"469","article-title":"Late onset uveitis in juvenile-type chronic polyarthritis controlled with prednisolone, cyclosporin A and methotrexate","volume":"16","author":"Kotaniemi","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0077","first-page":"309","article-title":"Uveitis as a cause of visual loss in arthritides and comparable conditions","volume":"28","author":"Kotaniemi","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0078","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.2147\/OPTH.S23646","article-title":"Long-term efficacy of adalimumab in the treatment of uveitis associated with juvenile idiopathic arthritis","volume":"5","author":"Kotaniemi","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0079","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.ophtha.2015.06.041","article-title":"The risk of intraocular pressure elevation in pediatric non-infectious uveitis","volume":"122","author":"Kothari","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0080","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1651-2227.2008.01091.x","article-title":"Topical treatment of uveitis resulting in adrenal insufficiency","volume":"98","author":"Kroger","year":"2009","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0081","first-page":"118","article-title":"Azathioprine versus placebo in patients with juvenile rheumatoid arthritis: a single center double blind comparative study","volume":"13","author":"Kvien","year":"1986","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0082","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/1756-0500-7-316","article-title":"Efficacy of adalimumab in young children with juvenile idiopathic arthritis and chronic uveitis: a case series","volume":"7","author":"La Torre","year":"2014","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0083","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0002-9394(69)92051-0","article-title":"Treatment of uveitis with methotrexate","volume":"67","author":"Lazar","year":"1969","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0084","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.3899\/jrheum.121180","article-title":"Response of pediatric uveitis to tumor necrosis factor-\u03b1 inhibitors","volume":"40","author":"Lerman","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0085","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajo.2015.04.016","article-title":"Uveitis reactivation in children treated with tumor necrosis factor alpha inhibitors","volume":"160","author":"Lerman","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0086","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ophtha.2013.09.048","article-title":"Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders","volume":"121","author":"Levy-Clarke","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0087","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1002\/art.22918","article-title":"Do tumor necrosis factor inhibitors cause uveitis? A registry-based study","volume":"56","author":"Lim","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0088","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3899\/jrheum.130594","article-title":"The safety and efficacy of noncorticosteroid triple immunosuppressive therapy in the treatment of refractory chronic noninfectious uveitis in childhood","volume":"41","author":"Little","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0089","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archophthalmol.2010.339","article-title":"Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis","volume":"129","author":"Lowder","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0090","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s00417-013-2275-x","article-title":"Adalimumab for juvenile idiopathic arthritis-associated uveitis","volume":"251","author":"Magli","year":"2013","journal-title":"Graefe Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0091","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bjo.2004.054239","article-title":"The use of low dose methotrexate in children with chronic anterior and intermediate uveitis","volume":"89","author":"Malik","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0092","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s00296-003-0308-1","article-title":"Therapeutic experience with infliximab in a patient with polyarticular juvenile idiopathic arthritis and uveitis","volume":"23","author":"Mangge","year":"2003","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0093","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s00417-015-3140-x","article-title":"Long-term efficacy of abatacept in pediatric patients with idiopathic uveitis: a case series","volume":"253","author":"Marrani","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0094","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1016\/j.ophtha.2014.06.050","article-title":"Long-term effects of tocilizumab therapy for refractory uveitis-related macular edema","volume":"121","author":"Mesquida","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0095","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0161-6420(01)00864-8","article-title":"Efficacy and safety of chlorambucil in intractable noninfectious uveitis: the Massachusetts eye and ear infirmary experience","volume":"109","author":"Miserocchi","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0096","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ophtha.2010.07.031","article-title":"Rituximab for uveitis","volume":"118","author":"Miserocchi","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0097","first-page":"320","article-title":"Golimumab treatment for complicated uveitis","volume":"31","author":"Miserocchi","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0098","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3109\/09273948.2013.844265","article-title":"Long-term treatment with golimumab for severe uveitis","volume":"22","author":"Miserocchi","year":"2014","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0099","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1136\/bjophthalmol-2015-306790","article-title":"Long-term treatment with rituximab in severe juvenile idiopathic arthritis-associated uveitis","volume":"100","author":"Miserocchi","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0100","article-title":"Psoriatic juvenile idiopathic arthritis associated with uveitis: a case report","volume":"2013","author":"Moretti","year":"2013","journal-title":"Case Rep Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0101","first-page":"1277","article-title":"Sulfasalazine reduces the number of flares of acute anterior uveitis over one year period","volume":"30","author":"Munoz-Fernandez","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0102","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00296-004-0537-y","article-title":"Evidence-based use of methotrexate in children with rheumatic diseases: a consensus statement of the working groups pediatric rheumatology Germany (AGKJR) and pediatric rheumatology Austria","volume":"25","author":"Niehues","year":"2005","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0103","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-2007-963094","article-title":"EBM analysis: classic DMARDs (disease-modifying antirheumatic drugs) and immunosuppressants in arthritis and uveitis","volume":"224","author":"Niehues","year":"2007","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0104","first-page":"1289","article-title":"Nonsteroidal anti-inflammatory drug therapy in chronic childhood iridocyclitis","volume":"142","author":"Olson","year":"1988","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0105","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0002-9394(00)00501-8","article-title":"Systemic toxicity of topical and periocular corticosteroid therapy in an 11-year-old male with posterior uveitis","volume":"130","author":"Ozerdem","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0106","first-page":"967","article-title":"Chlorambucil in the treatment of intractable uveitis associated with juvenile chronic arthritis","volume":"12","author":"Palmer","year":"1985","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0107","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jpeds.2013.03.047","article-title":"Methotrexate therapy may prevent the onset of uveitis in juvenile idiopathic arthritis","volume":"163","author":"Papadopoulou","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0108","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.ophtha.2008.03.027","article-title":"Immunohistochemical study of chronic nongranulomatous anterior uveitis in juvenile idiopathic arthritis","volume":"115","author":"Parikh","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0109","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0002-9394(03)00104-1","article-title":"Arthritis and uveitis in children. A pediatric rheumatology perspective","volume":"135","author":"Petty","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0110","first-page":"390","article-title":"International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0111","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10792-016-0265-9","article-title":"Sustained release dexamethasone intravitreal implant in juvenile idiopathic arthritis-related uveitis","volume":"37","author":"Pichi","year":"2017","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0112","doi-asserted-by":"crossref","DOI":"10.1159\/000368987","article-title":"Fast and successful management of intraocular inflammation with a single intravitreal dexamethasone implant","author":"Pleyer","year":"2014","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0113","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/annrheumdis-2017-212089","article-title":"ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis associated anterior uveitis","volume":"77","author":"Quartier","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0114","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3899\/jrheum.160908","article-title":"Subcutaneous tocilizumab may be less effective than intravenous tocilizumab in the treatment of juvenile idiopathic arthritis-associated uveitis","volume":"44","author":"Quesada-Masachs","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0115","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ophtha.2005.09.037","article-title":"Retrospective case review of pediatric patients with uveitis treated with infliximab","volume":"113","author":"Rajaraman","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0116","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1745-6215-15-14","article-title":"A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idopathic arthritis associated uveitis (SYCAMORE trial)","volume":"15","author":"Ramanan","year":"2014","journal-title":"Trials"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0117","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa1614160","article-title":"Adalimumab plus methotrexate for uveitis in juvenile idiopahic arthritis","volume":"376","author":"Ramanan","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0118","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","article-title":"Juvenile idiopathic arthritis","volume":"369","author":"Ravelli","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0119","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1002\/1529-0131(200106)44:6<1411::AID-ART235>3.0.CO;2-O","article-title":"Etanercept therapy in children with treatment-resistant uveitis","volume":"44","author":"Reiff","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0120","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1442-9071.2005.01062.x","article-title":"Infliximab for juvenile idiopathic arthritis-associated uveitis","volume":"33","author":"Richards","year":"2005","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0121","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000220600","article-title":"Intravitreal and orbital floor triamcinolone acetonide injections in noninfectious uveitis: a comparative study","volume":"42","author":"Roesel","year":"2009","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0122","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/eye.2008.114","article-title":"Orbital floor triamcinolone acetonide injections for the management of active non-infectious uveitis","volume":"23","author":"Roesel","year":"2009","journal-title":"Eye"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0123","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1002\/art.20288","article-title":"A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate","volume":"50","author":"Ruperto","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0124","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jaapos.2013.06.004","article-title":"Risk factors associated with the relapse of uveitis in patients with juvenile idiopathic arthritis: a preliminary report","volume":"17","author":"Saboo","year":"2013","journal-title":"J AAPOS"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0125","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1001\/archophthalmol.2007.59","article-title":"Short-term safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema in children","volume":"126","author":"Sallam","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0126","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0161-6420(01)00576-0","article-title":"Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160 patients","volume":"108","author":"Samson","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0127","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1755-3768.1991.tb02703.x","article-title":"Topical indometacin, a prostaglandin inhibitor, in acute anterior uveitis. A controlled clinical trial of non-steroid versus steroid anti-inflammatory treatment","volume":"69","author":"Sand","year":"1991","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0128","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2147\/OPTH.S54929","article-title":"Acute anterior uveitis after discontinuation of tocilizumab in a patient with rheumatoid arthritis","volume":"8","author":"Sato","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0129","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jpeds.2006.08.044","article-title":"Risk of new-onset uveitis in patients with juvenile idiopathic arthritis treated with anti-TNFalpha agents","volume":"149","author":"Saurenmann","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0130","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/rheumatology\/kel030","article-title":"Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis","volume":"45","author":"Saurenmann","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0131","first-page":"2444","article-title":"Azathioprine in patients with juvenile chronic arthritis: a longterm followup study","volume":"24","author":"Savolainen","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0132","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s003470050070","article-title":"Cyclosporin A in therapy of chronic uveitis in childhood","volume":"93","author":"Schlote","year":"1996","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0133","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/rheumatology\/keh658","article-title":"Etanercept and uveitis in patients with juvenile idiopathic arthritis","volume":"44","author":"Schmeling","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0134","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1002\/art.38741","article-title":"Efficacy and safety of adalimumab as the first and second biologic agent in juvenile idiopathic arthritis_ the German biologics JIA registry","volume":"66","author":"Schmeling","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0135","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/art.23440","article-title":"Uveitis following the use of tumor necrosis factor alpha inhibitors: comment on the article by Lim et al","volume":"58","author":"Scrivo","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0136","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3109\/09273948.2013.812222","article-title":"Recurrence of uveitis after discontinuation of infliximab","volume":"22","author":"Shakoor","year":"2014","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0137","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/ard.2006.065441","article-title":"Use of infliximab in juvenile onset rheumatological disease-associated refractory uveitis: efficacy in joint and ocular disease","volume":"66","author":"Sharma","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0138","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s12325-016-0315-8","article-title":"Impact of the topical ophthalmic corticosteroid loteprednol etabonate on intraocular pressure","volume":"33","author":"Sheppard","year":"2016","journal-title":"Adv Ther"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0139","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3928\/0191-3913-19990501-09","article-title":"Low-dose methotrexate in the treatment of severe juvenile rheumatoid arthritis and sarcoid iritis","volume":"36","author":"Shetty","year":"1999","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0140","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1093\/rheumatology\/ken298","article-title":"Loss of efficacy during long-term infliximab therapy for sight-threatening childhood uveitis","volume":"47","author":"Simonini","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0141","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/acr.20404","article-title":"Prevention of flare recurrences in childhood-refractory chronic uveitis: an open-label comparative study of adalimumab versus infliximab","volume":"63","author":"Simonini","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0142","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1546-0096-11-16","article-title":"Superior efficacy of adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: adalimumab as starting anti-TNF-a therapy in childhood chronic uveitis","volume":"11","author":"Simonini","year":"2013","journal-title":"Pediatr Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0143","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/acr.22214","article-title":"Current evidence of anti-tumor necrosis factor a treatment efficacy in childhood chronic uveitis: a systemic review and meta-analysis approach of individual drugs","volume":"66","author":"Simonini","year":"2014","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0144","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/art.20904","article-title":"A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis","volume":"53","author":"Smith","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0145","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.ophtha.2009.05.002","article-title":"Epidemiology and course of disease in childhood uveitis","volume":"116","author":"Smith","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0146","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.ophtha.2007.12.011","article-title":"Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis","volume":"115","author":"Sobrin","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0147","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/rheumatology\/keq308","article-title":"Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis patients","volume":"50","author":"Southwood","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0148","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0886-3350(98)80170-3","article-title":"Double-masked, placebo-controlled evaluation of loteprednol etabonate 0.5% for postoperative inflammation. Loteprednol etabonate post-operative inflammation study group 1","volume":"24","author":"Stewart","year":"1998","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0149","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.3899\/jrheum.130133","article-title":"High doses of infliximab in the management of juvenile idiopathic arthritis","volume":"40","author":"Tambralli","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0150","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/eye.2008.174","article-title":"Limited value of cyclosporine A for the treatment of patients with uveitis associated with juvenile idiopathic arthritis","volume":"23","author":"Tappeiner","year":"2009","journal-title":"Eye"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0151","doi-asserted-by":"crossref","first-page":"e521","DOI":"10.1111\/j.1755-3768.2011.02162.x","article-title":"Elevated laser flare values correlate with complicated course of anterior uveitis in patients with juvenile idiopathic arthritis","volume":"89","author":"Tappeiner","year":"2011","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0152","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3899\/jrheum.120010","article-title":"Is tocilizumab an effective option for treatment of refractory uveitis associated with juvenile idiopathic arthritis?","volume":"39","author":"Tappeiner","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0153","first-page":"936","article-title":"Temporal change in prevalence and complications of uveitis associated with juvenile idiopathic arthritis: data from a cross-sectional analysis of a prospective nationwide study","volume":"33","author":"Tappeiner","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0154","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3899\/jrheum.140410","article-title":"Abatacept in the treatment of severe, longstanding and refractory uveitis associated with juvenile idiopathic arthritis","volume":"42","author":"Tappeiner","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0155","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/acr.22649","article-title":"Impact of antiinflammatory treatment on the onset of uveitis in juvenile idiopathic arthritis: longitudinal analysis from a nationwide pediatric rheumatology database","volume":"68","author":"Tappeiner","year":"2016","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0156","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.3899\/jrheum.160231","article-title":"Evidence for tocilizumab as a treatment option in refractory uveitis associated with juvenile idiopathic arthritis","volume":"43","author":"Tappeiner","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0157","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/rheumatology\/keu457","article-title":"Occurrence of adverse events in patients with JIA receiving biologic agents: long-term follow-up in a real-life setting","volume":"54","author":"Tarkiainen","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0158","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ajo.2007.01.033","article-title":"Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss","volume":"143","author":"Thorne","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0159","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.ophtha.2009.12.003","article-title":"Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids","volume":"117","author":"Thorne","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0160","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/03009742.2010.517546","article-title":"Safety and efficacy of adalimumab treatment in Greek children with juvenile idiopathic arthritis","volume":"40","author":"Trachana","year":"2011","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0161","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3109\/09273948.2013.866254","article-title":"Tocilizumab for severe chronic anterior uveitis associated with juvenile idiopathic arthritis in a pediatric patient","volume":"22","author":"Tsang","year":"2014","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0162","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/rheumatology\/kem356","article-title":"Adalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitis","volume":"47","author":"Tynj\u00e4l\u00e4","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0163","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/ard.2006.058248","article-title":"Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis","volume":"66","author":"Tynj\u00e4l\u00e4","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0164","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jpeds.2006.04.058","article-title":"Adalimumab therapy for childhood uveitis","volume":"149","author":"Vazquez-Cobian","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0165","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archopht.1986.01050180081035","article-title":"Intravenous pulse methylprednisolone therapy in severe inflammatory eye disease","volume":"104","author":"Wakefield","year":"1986","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0166","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/S0161-6420(98)91120-4","article-title":"Cyclosporine therapy for severe sight-threatening uveitis in children and adolescents","volume":"105","author":"Walton","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0167","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000346847","article-title":"Bromfenac sodium 0.1%, fluorometholone 0.1% and dexamethasone 0.1% for control of ocular inflammation and prevention of cystoid macular edema after phacoemulsification","volume":"229","author":"Wang","year":"2013","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0168","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0022-3476(98)70232-X","article-title":"Methotrexate for resistant chronic uveitis in children with juvenile rheumatoid arthritis","volume":"133","author":"Weiss","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0169","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12348-012-0081-y","article-title":"Golimumab for the treatment of refractory juvenile idiopathic arthritis-associated uveitis","volume":"2","author":"William","year":"2012","journal-title":"J Ophthal Inflamm Infect"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0170","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/bjo.66.6.389","article-title":"Double-masked controlled clinical trial of 5% tolmetin versus 0.5% prednisolone versus 0.9% saline in acute endogenous nongranulomatous anterior uveitis","volume":"66","author":"Young","year":"1982","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0171","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3899\/jrheum.120583","article-title":"Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry","volume":"40","author":"Zannin","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.11.004_bib0172","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/acr.20115","article-title":"Abatacept for severe anti-tumor necrosis factor a refractory juvenile idiopathic arthritis-related uveitis","volume":"62","author":"Zulian","year":"2010","journal-title":"Arthritis Care Res"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017218304621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017218304621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:00:13Z","timestamp":1758733213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017218304621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":172,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0049017218304621"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2018.11.004","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update of the evidence based, interdisciplinary guideline for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2018.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}